Fresenius Medical Care, manufacturers of GranuFlo and NaturaLyte, also owns numerous dialysis centers across the country. One of those facilities, the Bessemer Kidney Center in Alabama, has been shut down following the deaths of two patients and the hospitalization of others. This is not good news for Fresenius, which also faces hundreds of GranuFlo and […]
Metal-on-metal hip implant devices, such as the DePuy ASR XL Acetabular System and the ASR Hip Resurfacing System, have failed at alarming rates. The failures often require additional painful and expensive surgeries for patients. A new study shows that patients also can suffer from an inflammation of the joint lining, which can lead to serious-long […]
Takeda Pharmaceutical’s Type 2 diabetes drug Actos (pioglitazone) has been linked to bladder cancer in patients who were treated with the drug over the course of several years. However, the latest Actos bladder cancer victim says that he took Actos for only two years before being diagnosed with bladder cancer. He joins hundreds of others […]
Although DePuy Orthopaedics recalled its ASR XL Acetabular System and ASR Hip Resurfacing System in 2010 after the devices failed at alarming rates, DePuy hip implant injuries remain a global concern. DePuy, and its parent corporation Johnson & Johnson, are now facing more than 150 hip implant lawsuits from South African patients. South African Woman’s […]
Television and print ads continually tout the impression that pharmaceutical companies have the consumers’ best interests at heart. Yet, many of these same drug makers are being fined for engaging in deceptive marketing practices and failing to warn consumers about known risks. A Case In Point: Sanofi Fined $52.8M for Engaging in Deceptive Practices French […]
A new study shows that nearly 25% of all vaginal bulge surgeries to treat pelvic organ prolapse (POP) fail and that symptoms generally return within seven years. The study’s results may complicate matters for the U.S. Food & Drug Administration, which is trying to determine whether vaginal bulge surgery or surgery using transvaginal mesh implants […]
Lipitor (atorvastatin), Pfizer’s best selling cholesterol drug, was approved by the U.S. Food & Drug Administration (FDA) in 1996 and quickly became one of the company’s best-selling drugs. Lipitor has generated over $125 billion in sales for Pfizer. However, it is now being linked to type 2 diabetes in women over 50. What Is Diabetes? […]
The first DePuy Orthopaedics hip implant injury trial representing a complaint consolidated in MDL (multi-district litigation) will begin in June 2013. The bellwether trial comes on the heels of the first non-MDL DePuy hip implant trial, in which a jury awarded the plaintiff $8.3 million in damages. What the Bellwether Trial Means to You DePuy […]
A growing number of women over the age of 50 are claiming that they developed Type II diabetes after taking Pfizer Inc.’s cholesterol drug Lipitor. They allege that Pfizer knew that Lipitor increased their risk of developing diabetes, but failed to warn them. Several lawsuits have already been filed against Pfizer, and plaintiffs are now […]
Merck & Company’s intrauterine device (IUD) NuvaRing has been linked to an increase in blood clots, pulmonary embolisms, strokes, heart attacks and more. The pharmaceutical giant is defending approximately 1,250 NuvaRing injury lawsuits, and injured victims will soon get their day in court, as trials are set to begin in October 2013. The Dangers of […]